Selcia provides integrated drug discovery, medicinal chemistry and isotope labelling services to the global life sciences industry and renowned research bodies.
The Birketts team was led by Partner Nigel Thompson, who was supported by John Kahn (Tax) and Matthew Grindley (Property).
Hans Fliri, Chairman of Selcia, commented: “This was a great opportunity for the shareholders of Selcia and for Selcia itself. We have previously worked with Birketts and wanted an experienced and dedicated team of lawyers to help us achieve our goal. The team at Birketts met our requirements in all aspects. The Birketts team provided first class expertise and client care and this gave us huge confidence in the whole process. It has been a real pleasure working with all at Birketts.”
Nigel Thompson said: “I am pleased that we were able to help Hans and his fellow shareholders achieve their aims and wish future success for all at Selcia as part of Eurofins.”